Free Trial

Biora Therapeutics (BIOR) Short Interest Ratio & Short Volume

Biora Therapeutics logo
$0.56 -0.06 (-9.89%)
(As of 12/20/2024 04:34 PM ET)

Biora Therapeutics Short Interest Data

Biora Therapeutics (BIOR) has a short interest of 290,200 shares, representing 6.64% of the float (the number of shares available for trading by the public). This marks a 12.44% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 57,475 shares to cover all short positions.

Current Short Interest
290,200 shares
Previous Short Interest
258,100 shares
Change Vs. Previous Month
+12.44%
Dollar Volume Sold Short
$565,890.00
Short Interest Ratio
2.5 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
4,523,000 shares
Float Size
4,370,000 shares
Short Percent of Float
6.64%
Today's Trading Volume
84,435 shares
Average Trading Volume
57,475 shares
Today's Volume Vs. Average
147%
Short Selling Biora Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Biora Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BIOR Short Interest Over Time

BIOR Days to Cover Over Time

BIOR Percentage of Float Shorted Over Time

Biora Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/2024290,200 shares $565,890.00 +12.4%6.6%2.5 $1.95
11/15/2024258,100 shares $547,172.00 +27.9%5.9%3.8 $2.12
10/31/2024201,800 shares $692,174.00 +43.3%4.8%4 $3.43
10/15/2024140,800 shares $779,187.20 -93.4%4.1%4.6 $5.53
9/30/20242,130,000 shares $1.07 million -0.9%6.3%9.9 $0.50
9/15/20242,150,000 shares $1.40 million +7.0%6.4%10.5 $0.65
8/31/20242,010,000 shares $1.40 million +21.8%5.9%10.4 $0.70
8/15/20241,650,000 shares $1.10 million +6.5%4.9%6.7 $0.67
7/31/20241,550,000 shares $1.04 million +16.5%4.4%6.3 $0.67
7/15/20241,330,000 shares $948,689.00 -2.9%3.7%5.2 $0.71
6/30/20241,370,000 shares $904,200.00 -2.8%3.9%5.3 $0.66
6/15/20241,410,000 shares $1.05 million +1.4%4.0%3.8 $0.75
5/31/20241,390,000 shares $889,322.00 +1.5%3.9%3.6 $0.64
5/15/20241,370,000 shares $979,550.00 -6.2%3.9%2.9 $0.72
4/30/20241,460,000 shares $956,884.00 +4.3%4.5%3.3 $0.66
4/15/20241,400,000 shares $868,000.00 +4.5%4.3%3.2 $0.62
3/31/20241,340,000 shares $1.47 million +13.6%4.2%2.9 $1.10
3/15/20241,180,000 shares $1.32 million +4.4%4.8%2.9 $1.12
2/29/20241,130,000 shares $1.48 million +58.1%4.6%2.6 $1.31
2/15/2024714,600 shares $578,111.40 +12.0%2.9%1.1 $0.81
1/31/2024638,300 shares $600,002.00 +7.8%2.5%1 $0.94
1/15/2024592,300 shares $746,298.00 +32.0%2.3%0.9 $1.26
12/31/2023448,800 shares $605,880.00 -33.5%1.7%0.8 $1.35
12/15/2023674,800 shares $917,728.00 +130.3%2.6%1.3 $1.36
11/30/2023293,000 shares $363,320.00 -55.2%1.3%0.6 $1.24
11/15/2023653,700 shares $875,958.00 +28.6%2.9%3.9 $1.34
10/31/2023508,200 shares $988,449.00 +7.4%2.3%3.8 $1.95
10/15/2023473,100 shares $865,773.00 +9.2%2.2%4.2 $1.83
9/30/2023433,300 shares $940,261.00 +38.5%2.0%4.8 $2.17
9/15/2023312,800 shares $706,928.00 +69.5%2.4%3.5 $2.26
8/31/2023184,600 shares $548,262.00 -9.0%1.5%1.6 $2.97
8/15/2023202,800 shares $636,792.00 -14.9%1.7%1.2 $3.14
7/31/2023238,300 shares $912,689.00 -12.8%1.9%1.3 $3.83
7/15/2023273,300 shares $1.09 million -26.3%2.1%1.5 $4.00
6/30/2023370,800 shares $1.43 million -9.6%2.9%2.1 $3.85
6/15/2023410,000 shares $1.75 million -0.3%3.2%2.2 $4.28
5/31/2023411,100 shares $1.84 million +5.2%3.6%2.4 $4.48
5/15/2023390,700 shares $1.31 million -7.7%3.5%2.8 $3.35
4/30/2023423,100 shares $1.03 million +0.2%3.7%3.1 $2.43
4/15/2023422,100 shares $1.10 million -0.1%4.8%1.6 $2.60
Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)

In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.

So please click here to see the details because a lot of people could get rich.
3/31/2023422,400 shares $1.17 million +24.5%4.8%0.2 $2.77
3/15/2023339,400 shares $868,864.00 -17.3%3.9%0.2 $2.56
2/28/2023410,200 shares $1.26 million -0.5%4.9%0.2 $3.06
2/15/2023412,400 shares $1.43 million -33.9%6.1%0.2 $3.46
1/31/2023623,900 shares $2.60 million -74.1%9.2%0.3 $4.17
1/15/20232,410,000 shares $10.29 million +428.5%35.4%1.1 $4.27
12/30/2022456,000 shares $37.53 million -96.1%6.7%0.5 $82.31
12/15/202211,730,000 shares $2.05 million -1.9%6.9%8.1 $0.17
11/30/202211,960,000 shares $2.93 million -7.6%7.1%9.1 $0.25
11/15/202212,950,000 shares $3.46 million -6.6%7.7%10.4 $0.27
10/31/202213,860,000 shares $5.28 million -2.5%8.4%8 $0.38
10/15/202214,210,000 shares $5.76 million +0.9%8.6%8.4 $0.41
9/30/202214,080,000 shares $6.83 million -4.4%8.5%8 $0.48
9/15/202214,730,000 shares $9.95 million -0.1%8.9%7.5 $0.68
8/31/202214,750,000 shares $10.65 million -7.1%8.9%7.2 $0.72
8/15/202215,880,000 shares $16.52 million -1.2%9.6%7.4 $1.04
7/31/202216,080,000 shares $11.26 million -10.2%9.8%8.8 $0.70
7/15/202217,910,000 shares $12.57 million No Change11.0%8.2 $0.70
4/15/202220,650,000 shares $20.65 million +5.1%N/A2.3 $1.00
3/31/202219,640,000 shares $22.78 million +17.0%N/A2 $1.16
3/15/202216,790,000 shares $19.98 million -8.7%N/A1.6 $1.19
2/28/202218,380,000 shares $24.81 million +23.4%N/A1.5 $1.35
2/15/202214,900,000 shares $28.31 million +17.1%N/A0.9 $1.90
1/31/202212,720,000 shares $18.19 million -2.2%N/A0.4 $1.43
1/15/202213,000,000 shares $21.97 million -15.5%N/A0.3 $1.69
12/31/202115,380,000 shares $32.14 million -1.0%N/A0.2 $2.09
12/15/202115,530,000 shares $40.38 million -14.3%N/A0.2 $2.60
11/30/202118,130,000 shares $56.75 million +7.5%N/A0.2 $3.13
11/15/202116,860,000 shares $58.50 million -23.2%N/A0.2 $3.47
10/29/202121,960,000 shares $79.06 million -4.1%N/A0.4 $3.60
10/15/202122,890,000 shares $48.98 million +112.9%N/A0.4 $2.14
9/30/202110,750,000 shares $16.34 million +21.6%N/A0.5 $1.52
9/15/20218,840,000 shares $8.54 million +134.5%N/A1.2 $0.97
8/31/20213,770,000 shares $3.35 million +11.5%N/A0.6 $0.89
8/13/20213,380,000 shares $5.61 million +31.5%N/A0.9 $1.66
7/30/20212,570,000 shares $5.78 million -29.4%N/A1.1 $2.25
7/15/20213,640,000 shares $9.35 million -11.9%N/A1.7 $2.57
6/30/20214,130,000 shares $14.74 million -0.5%7.1%2.2 $3.57
6/15/20214,150,000 shares $13.03 million +37.4%7.2%2.6 $3.14
5/28/20213,020,000 shares $7.82 million +7.1%6.7%3.5 $2.59
5/14/20212,820,000 shares $6.63 million -10.5%6.3%6 $2.35
4/30/20213,150,000 shares $9.61 million +4.7%7.0%7.1 $3.05
4/15/20213,010,000 shares $10.54 million -3.2%6.7%6.5 $3.50
3/31/20213,110,000 shares $14.37 million +2.0%6.9%6.3 $4.62
3/15/20213,050,000 shares $14.76 million +2.0%7.0%4.4 $4.84
2/26/20212,990,000 shares $16.65 million +2.1%6.8%3.1 $5.57
2/12/20212,930,000 shares $16.47 million +3.5%7.2%3.1 $5.62
1/29/20212,830,000 shares $20.69 million +2.5%7.0%3.1 $7.31
1/15/20212,760,000 shares $14.90 million No Change6.8%3.3 $5.40

BIOR Short Interest - Frequently Asked Questions

What is Biora Therapeutics' current short interest?

Short interest is the volume of Biora Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 290,200 shares of BIOR short. 6.64% of Biora Therapeutics' shares are currently sold short. Learn More on Biora Therapeutics' current short interest.

What is a good short interest ratio for Biora Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIOR shares currently have a short interest ratio of 2.0. Learn More on Biora Therapeutics's short interest ratio.

What is a good short interest percentage for Biora Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.64% of Biora Therapeutics' floating shares are currently sold short.

Is Biora Therapeutics' short interest increasing or decreasing?

Biora Therapeutics saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 290,200 shares, an increase of 12.4% from the previous total of 258,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Biora Therapeutics' float size?

Biora Therapeutics currently has issued a total of 4,523,000 shares. Some of Biora Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Biora Therapeutics currently has a public float of 4,370,000 shares.

How does Biora Therapeutics' short interest compare to its competitors?

6.64% of Biora Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Biora Therapeutics: Ensysce Biosciences, Inc. (8.83%), Genprex, Inc. (5.43%), Brainstorm Cell Therapeutics Inc. (3.03%), Aytu BioPharma, Inc. (2.00%), Viracta Therapeutics, Inc. (5.66%), Addex Therapeutics Ltd (1.87%), Biofrontera Inc. (12.11%), Conduit Pharmaceuticals Inc. (1.51%), CERo Therapeutics Holdings, Inc. (7.60%), Soligenix, Inc. (1.46%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Biora Therapeutics stock?

Short selling BIOR is an investing strategy that aims to generate trading profit from Biora Therapeutics as its price is falling. BIOR shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Biora Therapeutics?

A short squeeze for Biora Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOR, which in turn drives the price of the stock up even further.

How often is Biora Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOR, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:BIOR) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners